Skip to main content

Europe finances a genome-sequencing project on hypermutated tumours

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

Diario Médico has echoed that Fran Supek, head of the IRB Barcelona Genome Data Science group, has been awarded a Starting Grant from the European Research Council (ERC). This funding will be used to further his project. Supek aims to acquire greater knowledge of cancer biology in order to support the design of individualised therapies. To this end, he will analyse hypermutated tumours.

Link to Diario Médico

Attachment:

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).